Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...
DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's ...
StockStory.org on MSN
Why DexCom (DXCM) Shares Are Trading Lower Today
Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...
The report claims that inaccurate readings from the G7 device have resulted in hospitalizations and deaths among diabetic patients. According to Hunterbrook, an FDA inspection revealed DexCom made an ...
Stocktwits on MSN
DexCom Stock Slumps 10% After Hunterbrook Media Investigation Raises Concerns About Its G7 Device
Shares of DexCom (DXCM) declined 10% on Friday after investment firm Hunterbrook Capital disclosed a short position in the ...
Earlier this year, Purdue changed its pharmacy benefits manager to AffirmedRx. Now, some employees will have to pay thousands ...
Diabetes affects millions of Americans, and many don’t even realize they have it. Instead of relying on costly and ...
A s a person firmly ensconced in middle age — 57 percent of the way through life, to be precise, if government actuarial tables hold — I have begun to notice certain things not working quite as well ...
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback